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Vasoactive effects of supplemental pentobarbital anesthesia in the canine hindlimb microcirculation 
were documented in two groups of animals previously anesthetized with 30 mgjkg pentobarbital: Group 
1 with a 5 mgjkg intravenous (iv) bolus of pentobarbital (n = 8) and Group II with a 5 mg/kg 2-min 
iv infusion of pentobarbital (n = 7). In Group I, measurements at baseline (BL) and 5, 15, 20, and 30 
min (min) following pentobarbital administration included cardiac output, mean arterial pressure, total 
peripheral vascular resistance, common femoral artery flow (CFAQ) and resistance (CFAR), percentage 
hindhmb arteriovenous anastomotic shunt (AVA%), absolute shunt flow (AVAQ), and hindlimb nutrient 
capillary flow (NCQ). In Group II these same measurements were made, but the study was continued 
until all hindlimb hemodynamic parameters returned to control values. CFAQ, AVA%, AVAQ, and 
NCQ were significantly increased, and CFAR was decreased in both groups. CFAQ and NCQ remained 
significantly elevated at 30 min in Group I. In Group II CFAR, AVA%, and AVAQ remained elevated 
at 30 min, but did return to BL by 40 min, as did all other hindlimb hemodynamic parameters measured. 
Pentobarbital resulted in both AVA and arteriolar dilation, with an increase in the percentage total 
flow distributed to AVAs. These alterations of microcirculatory flow should be considered during in- 
vestigations of the distribution of peripheral blood flow, as well as during metabolic studies assessing 
arteriovenous substrate differences, if interpretative errors are to be avoided. 
This investigation was undertaken to define 
the microcirculatory effects of supplemental 
pentobarbital, an agent commonly used dur- 
ing hemodynamic studies in experimental an- 
imals. Previous studies have suggested that this 
agent may increase arteriovenous shunting [6, 
81. Although many canine hindlimb shunt 
studies have employed this anesthetic, to our 
knowledge, its specific effect on arteriovenous 
anastomoses has not been defined [5, 9, 10, 
12, 131. In the current investigation, alterations 
in hindlimb arteriovenous shunting induced 
by supplemental pentobarbital were quanti- 
tated using a radioactive microsphere tech- 
nique. 
MATERIALS AND METHODS 
Fifteen adult mongrel dogs, weighing 2 1 to 
37 kg, were anesthetized with an intravenous 
’ Liebig Fellow in Vascular Surgery. 
bolus of pentobarbital (30 mg/kg). Animals 
were intubated and mechanically ventilated 
maintaining arterial pH, pCOZ, and pOZ 
within physiologic ranges. Esophageal tem- 
perature remained stable and normal 
throughout the study. All dogs received lac- 
tated Ringer’s solution (10 ml/kg) intrave- 
nously during the experiment. A carotid ar- 
terial catheter, a transjugular central venous 
catheter, and a 7-Fr thermodilution Swan- 
Ganz catheter were appropriately positioned 
in each animal. Systemic arterial and central 
venous pressures were continuously moni- 
tored. A nonoccluding squarewave electro- 
magnetic flow probe was placed about the 
common femoral artery for continuous mea- 
surement of total femoral blood flow (CFAQ) 
using a square wave flowmeter. A NaI scin- 
tillation detector calibrated for the detection 
of technetium-99m, was fixed in position over 
the upper lung fields. Freshly prepared 99mT~- 
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labeled albumin microsopheres with a mean 
diameter of 20 grn (range 15-35 pm) were 
used in this experiment (3M Co., Minneap- 
olis). Spheres of this size, when injected in the 
femoral artery, are trapped in the hindlimb 
capillary microcirculation unless they pass 
through arteriovenous anastomoses, where- 
upon they ultimately lodge in the lung [lo]. 
A 22-gauge Teflon catheter was advanced into 
the common femoral artery for retrograde in- 
traarterial microsphere administration. Ra- 
dioactivity in individual syringes containing 
less than 0.1 ml of the suspension of micro- 
spheres (25,000 to 37,500 spheres) was mea- 
sured before and after injection. Syringes were 
flushed three times with 0.3 cc of autologous 
blood. Such injections did not alter total com- 
mon femoral artery flow. The radioactivity 
actually injected was determined taking into 
consideration the decay of 99mT~ as well as 
the residual radioactivity in the syringes after 
injection. Injection catheter radioactivity was 
measured, and found to be insignificant. Three 
minutes following each microsphere injection, 
the incremental change in radioactivity over 
the lung was quantified. Femoral venous in- 
jections of a known amount of microspheres 
were used to determine “ 100% shunt,” mea- 
sured as change in counts per minute (Acpm) 
of radioactivity over the lung field per milli- 
curie radioactivity injected. 
Percentage hindlimb shunt was calculated 
by the standard formula: 
Acpm over chest with intraarterial injection/ 
Percentage shunt (AVA%) = 
dose of intraarterial injection 
x 100. 
Acpm over chest with venous injection/ 
dose of venous injection 
The volume of blood flow through shunts 
(AVAQ) was calculated as AVAQ = CFAQ 
X AVA%shunt. The volume of blood flow not 
passing through arteriovenous anastomoses, 
and therefore available for capillary exchange 
as nutrient capillary flow (NCQ), was calcu- 
lated: NCQ = CFAQ - AVAQ. 
mon femoral artery resistance (CFAR = MAP/ 
CFAQ (litersfmin) X 79.9, dyn-secfcm’). Per- 
cent shunt, shunt flow (AVAQ), and nonshunt 
nutrient capillary flow (NCQ) were calculated 
as previously discussed. Data were analyzed 
by the Wilcoxon signed rank test and paired 
Student t test. Two experimental groups were evaluated. 
Forty minutes after induction of pentobarbital 
anesthesia hemodynamic parameters appeared 
stable. Baseline studies were then obtained. 
Group I subjects (n = 8) then received an 
intravenous bolus of pentobarbital (5 mg/kg) 
and hemodynamic studies were continued for 
the next 30 min. Group II subjects (n = 7) 
were studied after a 2-min continuous infusion 
of the same dose of supplemental pentobar- 
bital, with experimental observations con- 
tinuing for 40 min. In both Groups I and II 
the following parameters were measured at 
baseline (BL) and 5, 15, 20, and 30 min (and 
40 min in Group II) after pentobarbital in- 
jection: cardiac output (CO), central venous 
pressure (CVP), mean arterial pressure (MAP), 
systemic vascular resistance (SVR = MAP 
- CVP/CO X 79.9 dyn-set/cm’), and com- 
Effects of pentobarbital on cardiac output 
differed in the two groups (Table 1). In Group 
I significant abrupt increases in cardiac output 
occurred, and the elevations persisted for 30 
min after bolus administration. The minor 
increase in mean cardiac output observed in 
Group II animals never attained statistical sig- 
nificance. 
RESULTS 
Mean arterial pressure was significantly de- 
creased only at 5 min in Group I. Although 
mean arterial pressure decreased in Group II 
animals, changes from baseline approached 
but did not attain statistical significance at 
any time. Systemic vascular resistance was de- 
creased significantly in both groups, indicating 
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TABLE 1 
SYSTEMICEFFECTSOFPENTOBARBITAL' 
Baseline 5 min 15 min 20 min 30 min 40 min 
Cardiac output (I/min) 
Group I 3.96 + 1.11 5.53 + 2.26* 5.32 k 1.62’ 4.91 f 1.09* 5.40 + 1.24** - 
Group II 3.96 f 0.78 4.19 f 0.86 4.08 f 0.86 4.15 If: 0.71 4.38 f 1.1 I 4.70 + 0.88 
Mean arterial pressure (mm Hg) 
Group I 140 f 17 136 + 19* 137 k 18 138 f 18 140 r 15 - 
Group II 141 + 13 135 + 17 132 + 17 133 f 12.2 133 rfr 14 142 k 12 
Systemic vascular resistance (dyn-see/cm’) 
Group I 3048 f 1139 2144 + 729+* 2178 ? 652** 2297 f 641* 2147 + 588* - 
Grow II 3028 + 620 2751 f 573 2778 + 612 2728 + 416’ 2632 f 553** 2575 f 568** 
’ Data described as mean f 1 SD. Comparisons to contl 
* P < 0.05. 
** P < 0.02. 
that pentobarbital caused vasodilatation in- 
dependent of the speed of administration. 
Major effects on hindlimb hemodynamics 
were apparent after supplemental pentobar- 
bital administration (Table 2). Common fem- 
oral artery flow in Group I increased signifi- 
cantly throughout the period of observation. 
In Group II, the peak increase in CFAQ oc- 
curred at 20 min, but returned toward control 
values by 30 min. Decreases in hindlimb vas- 
cular resistance were observed in both groups, 
but had returned to levels indistinguishable 
from control values by 30 min in Group I, 
and by 40 min in Group II. 
Percentage hindlimb shunt more than dou- 
bled in each group. In Group I mean per- 
centage shunt increased from 3.2% at baseline 
to 8.2% at 5 min, and in Group II from a 
baseline of 2.1 to 6.0% at 20 min. Percentage 
hindlimb shunt returned to values near control 
levels by 30 min in Group I, and by 40 min 
in Group II. 
Reflecting this redistribution of blood flow 
to AVA, absolute shunt flow (AVAQ) more 
than tripled in both groups. Bolus pentobar- 
bital administration resulted in an early in- 
crease of mean AVAQ from 3.9 ml/min base- 
line to 12.3 ml/min at 5 min with a subsequent 
return toward control levels by 30 min. In 
Group II peak shunt flow occurred at 20 min, 
being similar in magnitude to the maximum 
.ol baseline data using Student’s t or Wilcoxon tests. 
shunt flow in the Group I animals, 12.9 ml/ 
min. By 40 min in Group II, AVAQ also had 
returned close to control values. 
Hindlimb nutrient capillary flow (NCQ) in 
Group I remained significantly elevated com- 
pared to baseline values throughout the study 
period. In Group II, mean NCQ increased 
from 142 ml/min at baseline to a maximum 
of 190 ml/min at 20 min, returning toward 
control levels by 40 min. Maximum derange- 
ments in the hindlimb microcircuation oc- 
curred in Group I at the initial 5-min obser- 
vation period, and were noted at 20 min in 
Group II. 
DISCUSSION 
The radioactive microsphere technique for 
study of canine hindlimb arteriovenous an- 
astomoses was first introduced by Lopez-Ma- 
jano et al. [lo]. Many investigators have sub- 
sequently evaluated the effects of pharmaco- 
logic and physiologic manipulations on these 
naturally occurring arteriovenous shunts, but 
despite this, the functional significance and 
physiologic control of AVA remain poorly 
understood. 
Several suggestions that pentobarbital may 
alter arteriovenous shunting exist in the lit- 
erature. Kaihara and colleagues reported that 
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significantly higher with left atria1 injection of 
radioactive microspheres in dogs anesthetized 
with 25 to 30 mg/kg of pentobarbital, than 
occurred with similar microsphere injections 
in unanesthetized dogs [S]. These investigators 
speculated that this might result from “di- 
version of these spheres around systemic vas- 
cular beds” [8]. Rhodes and his coauthors re- 
ported existence of “a wider variation in per- 
cent shunting in pentobarbital anesthetized 
dogs” [ 121. Another investigation on regional 
distribution of blood flow during pentobarbital 
administration noted marked increases in lung 
microsphere entrapment and decreased skel- 
etal muscle blood flow [6]. Although these 
investigators speculated that systemic arterio- 
venous shunting resulted from pentobarbital 
administration, shunting was never quanti- 
tated by direct measurement. 
Results of our study indicate that pento- 
barbital acts as an arterial dilator when ad- 
ministered by intravenous bolus or slow in- 
fusion in dogs already anesthetized with this 
drug. Hemodynamic responses to pentobar- 
bital appear similar when administered to an- 
imals already anesthetized with this barbitu- 
rate or when administered to dogs previously 
anesthetized with other agents such as cho- 
loralose or urethane [ 1 I]. Lowering of arterial 
pressure and systemic vascular resistance fol- 
lowing administration of 5 mg/kg of pento- 
barbital are comparable with drug induced 
vasodilation which has been previously re- 
ported [6, 1 I]. Because the effects of other 
anesthetic agents on hindlimb arteriovenous 
shunt are unknown, and because of the per- 
vasive use of pentobarbital anesthesia in re- 
search related to arteriovenous anastomotic 
blood flow, pentobarbital was used to induce 
anesthesia in this study. This dose of pento- 
barbital was chosen for study because it is a 
frequently used anesthetic supplement in ca- 
nine experiments. 
An important microcirculatory derange- 
ment induced by supplemental pentobarbital 
anesthetic is an increase in percent of hindlimb 
shunt. This phenomenon may be due to re- 
laxation or active dilation of AVAs. Accord- 
ingly, increased volume flow through such 
shunts may theoretically result from either 
“opening” of the AVA, or by increases in vol- 
ume flow through AVA following proximal 
arterial dilation [9]. Both phenemona may 
have been operative in our experiments. Pen- 
tobarbital also increased hindlimb nutrient 
capillary blood flow, which may result from 
arterial dilation. Previous “vital” studies have 
suggested that pentobarbital causes venodi- 
lation as assessed by increased venular size, 
in addition to arterial dilation [7]. The in- 
creased venular size, reported in the former 
study, may reflect increased arteriovenous 
shunting, greater flow with arteriolar dilation, 
or primary venodilation. Specific mechanisms 
by which pentobarbital causes vasodilation are 
unclear, but may include inhibition of vaso- 
constriction by endogenous epinephrine, by 
acting as a “calcium entry blocker,” or by 
inhibition of vasomotion [ 1, 21. 
Results of the present investigation may ex- 
plain some of the reported variability in per- 
cent hindlimb shunt and earlier controversy 
regarding the normal baseline percent shunt 
in canine hindlimbs when pentobarbital was 
the anesthetic utilized, since times of anes- 
thetic administration and shunt measurement 
were probably not controlled [3, 4, 10, 121. It 
has been previously suggested this variability 
may have been due to the lack of control of 
arterial blood gases [3, 41. Experiments from 
our laboratories have suggested that this is not 
true [13]. 
It is apparent that intravenous pentobarbital 
alters both systemic and hindlimb hemody- 
namics when administered as a supplemental 
dose in the previously anesthetized dog. All 
hindlimb hemodynamic parameters (CFAQ, 
CFAR, AVA%, AVAQ, and NCQ) in this 
study returned to the level of controls by 40 
min when the drug was administered slowly. 
Alterations in systemic hemodynamics were 
somewhat less abrupt and less sustained with 
the slower administration compared to the 
bolus administration of supplemental pen- 
tobarbital anesthesia. Using pentobarbital 
anesthesia in studies of extremity shunting 
utilizing radioactive microspheres is accept- 
able if the vasoactive effects of the drug are 
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considered. The effects of other anesthetic 
agents on arteriovenous shunting are un- 
known. One may conclude from our data that 
experimental measurements in arteriovenous 
shunt studies as well as in metabolic studies 
investigating arteriovenous substrate differ- 
ences should not begin, and baseline values 
should not be obtained, until 30 to 40 min 
following initial or supplemental administra- 
tion of pentobarbital, if interpretive errors are 
to be avoided. 
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